The Impact of a Forced Non-Medical Switch of Inhaled Respiratory Medication Among Patients with Asthma or Chronic Obstructive Pulmonary Disease: A Patient Survey on Experience with Switch, Therapy Satisfaction, and Disease Control

PURPOSE: Budesonide/formoterol pressurized metered-dose inhaler (pMDI) was removed from a Medicare Part D formulary, and patients switched to fluticasone-based dry powder inhaler (DPI) therapies. This study describes the experience, satisfaction, and disease control among patients with asthma or chr...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Ileen, Wada, Keiko, Burudpakdee, Chakkarin, Ghai, Chirag, Tan, Laren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445512/
https://www.ncbi.nlm.nih.gov/pubmed/32903885
http://dx.doi.org/10.2147/PPA.S242215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445512/
https://www.ncbi.nlm.nih.gov/pubmed/32903885
http://dx.doi.org/10.2147/PPA.S242215

Ejemplares similares